Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Comparative mortality in medically treated aortic regurgitation.

Richard B Singer

    Journal of Insurance Medicine (New York, N.Y.)
    |April 24, 2004
    PubMed
    Summary

    Medically treated aortic regurgitation patients with no functional impairment (NYHA class I) show no excess mortality. However, those with NYHA class II, III, or IV impairments face significantly higher mortality rates, especially with advanced disease.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The Cancer Mortality Risk Project - Cancer Mortality Risks by Anatomic Site: Part 1 - Introductory Overview; Part II - Carcinoma of the Colon: 20-Year Mortality Follow-up Derived from 1973-2013 (NCI) SEER*Stat Survival Database.

    Journal of insurance medicine (New York, N.Y.)·2018
    Same author

    A brief historical sketch of the Association of Life Insurance Medical Directors of America (ALIMDA), the predecessor of the American Academy of Insurance Medicine (AAIM).

    Journal of insurance medicine (New York, N.Y.)·2011
    Same author

    Mortality in active adults age 70-79 years in relation to performance in a long-distance corridor walk.

    Journal of insurance medicine (New York, N.Y.)·2009
    Same author

    Comparative mortality in asymptomatic men issued standard insurance with routine ECG classified as normal or with minor T wave changes.

    Journal of insurance medicine (New York, N.Y.)·2009
    Same author

    Comparative mortality in HIV-infected patients in Denmark, 1995-2005.

    Journal of insurance medicine (New York, N.Y.)·2009
    Same author

    Mortality in older adults in relation to daily activity energy expenditure.

    Journal of insurance medicine (New York, N.Y.)·2008

    Area of Science:

    • Cardiology
    • Clinical Medicine
    • Public Health

    Background:

    • Follow-up studies on medically treated aortic regurgitation (AR) patients yield conflicting results.
    • This study focuses on patients receiving only medical treatment for AR, excluding surgical interventions.
    • Understanding mortality in medically managed AR is crucial for patient care and treatment strategies.

    Purpose of the Study:

    • To present a comparative mortality analysis of medically treated patients with aortic regurgitation.
    • To assess excess mortality rates based on New York Heart Association (NYHA) functional classifications.
    • To provide a clearer understanding of the long-term prognosis for patients with AR managed non-surgically.

    Main Methods:

    • Utilized the triple decrement life table analysis approach.
    • Incorporated data on death, withdrawal due to surgery, and end of follow-up (FU).
    • Calculated exposures, observed/expected deaths, excess death rates (EDR), and mortality ratios (MR).

    Main Results:

    • No significant excess mortality was observed in NYHA class I patients compared to the general US population.
    • NYHA class II patients exhibited an average excess death rate of 28 per 1000 per year over 0-10 years.
    • NYHA class III and IV patients showed very high excess death rates (205 per 1000 per year over 0-5 years) and a mortality ratio of 1100%.

    Conclusions:

    • Medically managed AR patients with no functional impairment (NYHA class I) have a comparable mortality risk to the general population.
    • Significant excess mortality is evident in NYHA class II patients, and extremely high in NYHA class III/IV patients.
    • Despite no excess mortality in class I, long-term outlook for AR patients includes high risks of heart failure and valve surgery.

    Related Experiment Videos